Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
20,111,055
-
Shares change
-
+1,361,987
-
Total reported value, excl. options
-
$157,862,948
-
Value change
-
+$10,123,034
-
Put/Call ratio
-
5.67%
-
Number of buys
-
39
-
Number of sells
-
-18
-
Price
-
$7.85
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2016
86 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2016.
NovoCure Ltd - Common Stock (NVCR) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,111,055 shares
of 111,111,111 outstanding shares and own 18.1% of the company stock.
Largest 10 shareholders include FMR LLC (4,889,661 shares), VANGUARD GROUP INC (2,722,428 shares), BlackRock Fund Advisors (2,691,801 shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1,818,079 shares), StepStone Group LP (1,815,479 shares), PEREGRINE CAPITAL MANAGEMENT LLC (1,127,486 shares), STATE STREET CORP (860,129 shares), COURAGE CAPITAL MANAGEMENT LLC (500,000 shares), BlackRock Institutional Trust Company, N.A. (479,383 shares), and NORTHERN TRUST CORP (477,754 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.